Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01896414 · ClinicalTrials.gov registry record · NA
Metabolic Actions of Omega-3 Fatty Acids
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01896414 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 40 participants.
The verdict
NCT01896414, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The metabolic syndrome raises the risk of heart disease and is currently at epidemic proportions in the U.S. It consists of 3 of the following components: central obesity, high triglycerides, low HDL, abnormal blood pressure and impaired fasting glucose levels. Previous studies have suggested that omega-3 fish oil may influence some of these components but the mechanisms involved are not well understood. Therefore, this proposal will investigate how omega-3 fish oils affect inflammation, lipids and fat breakdown by comparing it to placebo. Favorable outcomes from this study could translate into a new approach to improve heart disease risk in men and women with the metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT EPA (marine fatty acids)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01896414
The ClinicalTrials.gov registry entry for NCT01896414 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01896414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01896414 about?
NCT01896414 is a clinical study titled "Metabolic Actions of Omega-3 Fatty Acids". The metabolic syndrome raises the risk of heart disease and is currently at epidemic proportions in the U.S. It consists of 3 of the following components: central obesity, high triglycerides, low HDL, abnormal blood pressure and impaired fasting glucose levels. Previous studies have suggested that o...
What is the current status of trial NCT01896414?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-07. Estimated completion is 2016-05-30.
What interventions are being tested in trial NCT01896414?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), EPA (marine fatty acids) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01896414?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.